Analyst Reco. Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:30:12 2026-01-21 am EST			5-day change	1st Jan Change
338.72 ^USD	+2.33%		+2.85%	+3.38%

Jan. 20	Global drugmakers rush to boost US presence as tariff threat looms	RE
Jan. 15	Espiria Hållbar Framtid Rises 0.4 Percent in December — Increased Holdings in Epiroc and Afry	FW

Analyst Reco.

Jan. 08	Goldman Sachs Adjusts Price Target on Amgen to $403 From $400, Maintains Buy Rating	MT
Jan. 08	RBC Raises Price Target on Amgen to $335 From $330, Keeps Outperform Rating	MT
Jan. 07	Amgen Shares Rise After Upgrade From UBS	MT
Jan. 07	UBS Upgrades Amgen to Buy From Neutral, Raises Price Target to $380 From $317	MT
Dec. 30	Argus Adjusts Price Target on Amgen to $360 From $310, Maintains Buy Rating	MT
Dec. 12	Morgan Stanley Adjusts Amgen Price Target to $304 From $329, Maintains Equalweight Rating	MT
Dec. 10	Wells Fargo Adjusts Price Target on Amgen to $325 From $300, Maintains Equalweight Rating	MT
Dec. 10	HSBC Adjusts Price Target on Amgen to $425 From $381, Maintains Buy Rating	MT
Dec. 03	BMO Capital Adjusts Price Target on Amgen to $372 From $335, Maintains Outperform Rating	MT
Dec. 02	Janux dives as gaps in prostate cancer study data worry investors	RE
Nov. 19	HSBC Adjusts Price Target on Amgen to $381 From $343, Maintains Buy Rating	MT
Nov. 18	Daiwa Securities Adjusts Price Target on Amgen to $370 From $310, Maintains Outperform Rating	MT
Nov. 14	Piper Sandler Adjusts Price Target on Amgen to $381 From $342, Maintains Overweight Rating	MT
Nov. 13	Scotiabank Initiates Amgen at Sector Outperform With $385 Price Target	MT
Nov. 11	Deutsche Bank Adjusts Amgen Price Target to $285 From $280, Maintains Hold Rating	MT
Nov. 10	DZ Bank Adjusts Price Target on Amgen to $364 From $335	MT
Nov. 06	Cantor Fitzgerald Adjusts Price Target on Amgen to $315 From $305, Maintains Neutral Rating	MT
Nov. 06	Guggenheim Adjusts Price Target on Amgen to $305 From $288, Maintains Neutral Rating	MT
Nov. 05	Goldman Sachs Adjusts Price Target on Amgen to $400 From $405, Maintains Buy Rating	MT
Nov. 05	Morgan Stanley Adjusts Price Target on Amgen to $329 From $333, Maintains Equalweight Rating	MT
Nov. 05	Wells Fargo Adjusts Amgen Price Target to $300 From $280, Maintains Equal Weight Rating	MT
Nov. 05	Morgan Stanley Trims Price Target on Amgen to $329 From $333, Keeps Equalweight Rating	MT
Nov. 04	Zai Lab updates on Amgen's bemarituzumab Phase 1B/3 Fortitude-102 study	RE
Nov. 04	Zai Lab Limited Announces Update on Amgen's Bemarituzumab Phase 1B/3 Fortuda-102 Study	CI
Nov. 04	MORNING BID AMERICAS-Nerves rising about frothy valuations	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Analyst Reco. Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Analyst Reco.

Filters